Search for: "ELI LILLY & CO."
Results 981 - 1000
of 1,007
Sorted by Relevance
|
Sort by Date
28 Oct 2011, 7:00 am
Eli Lilly & Co., 2009 WL 5216930, at *12 (E.D.N.Y. [read post]
19 Feb 2011, 3:32 pm
Co. v. [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
3 May 2014, 8:56 am
Indiana Harbor Belt Railroad Co., 461 F.3d 844 (7th Cir. 2006) (affirming summary judgment in disparate treatment discharge case, and noting judicial tendency to require “comparability” between plaintiffs and comparison group as a “natural response to cherry-picking by plaintiffs”); Miller v. [read post]
11 Jul 2008, 4:30 am
Part I – Spicy IP), India: Discussion of grant of Indian patents to Cipla for Fosamax derivative and Nexium derivative: (Spicy IP), India: Draft National Biotechnology Regulatory Authority Bill: (Spicy IP), Ivory Coast: Ivorians increasingly choose fake medicines on price: (Afro-IP), Mexico: New Mexican medicaments approvals regime: an early report: (IP tango), UK: Leave to appeal refused in trade mark infringement proceedings between Eli Lilly and 8PM Chemist concerning… [read post]
21 Jun 2019, 3:00 am
Three drug companies – Amgen, Merck, and Eli Lilly – and the nation’s largest advertising group announced they were suing the administration over its new policy of requiring prescription drug manufacturers to disclose list prices in television ads. [read post]
21 Jan 2007, 5:42 pm
We have not seen, in any of the Court’s recent opinions, discussion of patents as “monopolies,” along the lines of Justice Douglas’ concurrence in Great Atlantic & Pacific Tea Co. v. [read post]
2 Aug 2014, 6:05 am
In the course of the welding fume litigation, defense counsel sought underlying data and documentation from a study published by Dr. [read post]
11 Mar 2010, 12:23 pm
Eli Lilly & Co., 536 F. [read post]
29 Dec 2010, 12:54 pm
Eli Lilly & Co., 620 F.3d 121 (2d Cir. 2010). [read post]
16 Mar 2008, 10:19 am
Because [Joey] Langston was awarded state contracts by Hood to sue prescription drug-maker Eli Lilly and MCI, Hood said he could not prosecute him. [read post]
4 Mar 2012, 9:02 am
Next year, the Supreme Court’s Daubert decision will turn 20. [read post]
16 Aug 2007, 7:20 am
In our cases, we like to talk to the prescribing doctors whenever we can. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
11 Apr 2017, 3:01 pm
(Pix © Larry Catá Backer 2016) I will be teaching a course on Corporate Social Responsibility. [read post]
31 May 2019, 9:47 am
Anheuser-Busch Cos., No. 19-cv-218-wmc (W.D. [read post]
10 Feb 2023, 4:44 am
In the third edition’s chapter on statistics, David Kaye and co-author, the late David A. [read post]
15 Jun 2024, 6:31 am
Moelis & Co., the Delaware Court of Chancery upended market practice by invalidating certain provisions of a shareholder agreement that were deemed to deprive the Board of Directors of its authority to manage the business and affairs of a corporation under Delaware General Corporation Law (“DGCL”) §141(a). [read post]
15 Jun 2024, 6:31 am
Moelis & Co., the Delaware Court of Chancery upended market practice by invalidating certain provisions of a shareholder agreement that were deemed to deprive the Board of Directors of its authority to manage the business and affairs of a corporation under Delaware General Corporation Law (“DGCL”) §141(a). [read post]
1 May 2008, 11:21 am
Sturm, Ruger & Co., 761 N.Y.S.2d 192 (N.Y.A.D. 2003), the court held, among a lot of other things, that using public nuisance against makers of legal products would invite "a host of societal problems. . . into the courthouse":[A] common-law public nuisance cause of action. . .will, in our judgment, likely open the courthouse doors to a flood of limitless, similar theories of public nuisance, not only against these defendants, but also against a wide and varied array of… [read post]
